11/05/2025 | Press release | Distributed by Public on 11/05/2025 08:45
Orrick advised capAI plc (LSE: CPAI) on the admission to trading of its ordinary shares on the OTCQB Venture Market (OTCQB) in the United States of America (US).
capAI is an active artificial intelligence (AI) incubator and operating business, whose principal activity is the development and commercialisation of AI technologies through its strategic framework: Identify, Incubate and Invent.
The trading of capAI's ordinary shares on OTCQB commenced on 5 November 2025 under the ticker "CPIQF."
There was no capital raise associated with this cross trade and the ordinary shares will continue to trade on capAI's primary listing market, the main market for listed securities of London Stock Exchange plc.
Trading on OTCQB is expected to enhance capAI's international presence, liquidity and access to additional AI-focused investors.
capAI's ordinary shares will be available to US investors during US working hours and priced in US Dollars and should lead to easier cross-border trading for potential US investors.
The Orrick team is led by Ed Dyson, supported by Ed Lukins and Abigail Parkin.